Cost-effectiveness analyses: A basic overview for dermatologists

Journal of Cutaneous Medicine and Surgery

Volumn 5, Issue 3, 2001, Pages 217-222

  Chen, Suephy C ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; HEALTH CARE POLICY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR;

COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DERMATOLOGY; ECONOMICS, MEDICAL; HEALTH CARE COSTS; HUMANS; QUALITY-ADJUSTED LIFE YEARS;

EID: 0034950713     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1007/s102270000007     Document Type: Article

References (32)

1. Dermatologists in Kaiser Permanente-Northern California
2. Continuous quality improvement and outcome research: Data for dermatologists to live by
3. We must have a "cost-effective" change of attitude
4. Dermatologists must prove their cost-effectiveness
5. Public education versus cost-effectiveness study
6. Cost-comparison analysis versus cost-effectiveness analysis: An important difference
7. The role of cost-effectiveness analysis in health and medicine
8. Recommendations of the panel on cost-effectiveness in health and medicine
9. Recommendations for reporting cost-effectiveness analyses
10. Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group
11. Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Group
12. Life: Quality, value and justice
13. Interpretation of cost-effectiveness analyses
14. Economic foundations of cost-effectiveness analysis
15. Cost-effectiveness of tests to assess the risk of sudden death after acute myocardial infarction
16. Cost-effectiveness of assessment and management of risk factors
17. Allocating resources to health care: Is the QALY (Quality Adjusted Life Year) a technical solution to a political problem?
18. Qualms about QALYs
19. Healthy-years equivalents versus quality-adjusted life years: In pursuit of progress
20. Quality-adjusted life years, utility theory, and healthy-years equivalents
21. Preferences for outcomes in economic evaluation: An economic approach to addressing economic problems
22. An alternative to QALYs: The saved young life equivalent (SAVE)
23. The value of DALY life: Problems with ethics and validity of disability adjusted life years
24. Dollars may not buy as many QALYs as we think: A problem with defining quality-of-life adjustments
25. Preferences for health outcomes. Comparison of assessment methods
26. Utility functions for life years and health states
27. Health-related quality of life measurement for evaluation research and policy analysis
28. The influence of ill-health experience on the valuation of health
29. Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents
30. Whose utilities for decision analysis?